vinpocetine has been researched along with Acute Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Ding, L; Gao, Y; Gong, P; He, X; Song, W; Wei, L; Xu, J; Yang, Y; Yin, W; Zhang, J | 1 |
| Abdel-Razek, NS; Salem, HA; Wadie, W | 1 |
| Borghi, SM; Bussmann, AJC; Casagrande, R; Coelho-Silva, L; Crespigio, J; Fattori, V; Giroldo, AC; Guazelli, CFS; Ludwig, NG; Mazzuco, TL; Verri, WA | 1 |
3 other study(ies) available for vinpocetine and Acute Kidney Failure
| Article | Year |
|---|---|
Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF-κB pathway and activation of Nrf2/ARE pathway in rats.
Topics: Acute Kidney Injury; Animals; Antioxidant Response Elements; Cisplatin; Male; NF-E2-Related Factor 2; NF-kappa B; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Vinca Alkaloids | 2020 |
Phosphodiesterase (1, 3 & 5) inhibitors attenuate diclofenac-induced acute kidney toxicity in rats.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cilostazol; Creatinine; Diclofenac; Kidney; Male; NF-kappa B; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Wistar; Sildenafil Citrate; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2021 |
Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-κB activation in mice.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cytokines; Diclofenac; Kidney; Male; Mice; NF-kappa B; Nootropic Agents; Oxidative Stress; Protective Agents; Vinca Alkaloids | 2017 |